PolymarketVerificar disponibilidadeSem KYC2% de taxaDados de resolução verificadosBem calibradoProbabilidade implícita atual
Não 94.1%
Qualidade do mercado
67 / 100
Qualidade médiaVolume 24h
14,5 €
Liquidez
31,8 mil €
Alta liquidezCompra / Venda
5.0% / 6.0%
Spread
1.0 pt
Spread apertadoComentários
7
Dados do mercado
Atualizado há 7 minutos
4/05/26, 14:41 UTC1/01/27, 04:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHantavirus pandemic in 2026?
Manifold MarketsHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsWill the CDC weaken vaccine recommendation against _____ for children and adolescents in 2026?
FutuurRegras
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Mercados abertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 30,4 mil
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 652,8 mil
- Volume 24h
- € 3,5 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volume total
- € 1,6 mi
- Volume 24h
- € 2,9 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 mais resultados
- Volume total
- € 865,3 mil
- Volume 24h
- € 2,7 mil
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volume total
- € 915,3 mil
- Volume 24h
- € 1,4 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volume total
- € 84 mil
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Perguntas frequentes
- Quais são as probabilidades atuais de Hantavirus vaccine in 2026??
- A Polymarket cota No em 94% em 9 de setembro de 2026.
- Quando Hantavirus vaccine in 2026? é resolvido?
- Hantavirus vaccine in 2026? deverá ser resolvido em 1 de janeiro de 2027.
- Como Hantavirus vaccine in 2026? é liquidado?
- A Polymarket liquida este mercado da seguinte forma: This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.